Iovance Biotherapeutics (IOVA) Goodwill & Intangibles (2023 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Goodwill & Intangibles of $329.7 million for Q1 2026, up 2.24% year-over-year from $322.5 million in Q1 2025, and down 1.63% quarter-over-quarter from $335.2 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Goodwill & Intangibles (2023 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Goodwill & Intangibles for 4 consecutive years, with $329.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 2.24% year-over-year to $329.7 million; the TTM figure through Mar 2026 stood at $329.7 million (up 2.24% YoY), while the FY2025 annual figure was $335.2 million, up 18.68% from the prior year.
- Goodwill & Intangibles fell to $329.7 million in Q1 2026 per IOVA's latest filing, from $335.2 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $335.3 million in Q3 2025 and bottomed at $223.6 million in Q3 2023.
- Historically, Goodwill & Intangibles has averaged $292.5 million across 4 years, with a median of $296.3 million in 2025.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles soared 49.19% — and 2025, when it grew 0.51%.
- Iovance Biotherapeutics' Goodwill & Intangibles stood at $229.3 million in 2023, then rose by 23.18% to $282.4 million in 2024, then grew by 18.68% to $335.2 million in 2025, then slipped by 1.63% to $329.7 million in 2026.
- Business Quant data shows IOVA's Goodwill & Intangibles at $329.7 million in Q1 2026, $335.2 million in Q4 2025, and $335.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 330.24 Mn |
| Mar 31, 2026 | 329.70 Mn |
| Dec 31, 2025 | 335.16 Mn |
| Sep 30, 2025 | 335.31 Mn |
| Jun 30, 2025 | 296.25 Mn |
| Mar 31, 2025 | 322.48 Mn |
| Dec 31, 2024 | 282.40 Mn |
| Sep 30, 2024 | 333.61 Mn |
| Mar 31, 2024 | 294.30 Mn |
| Dec 31, 2023 | 229.26 Mn |
| Sep 30, 2023 | 223.61 Mn |
| Jun 30, 2023 | 235.51 Mn |